Sign in

CIK 0002020932

  • Non-accelerated filer
  • Emerging growth company

AgomAb Therapeutics NV

Sign in to watch
Ticker
AGMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Belgium
Entity type
Other
Phone
+32 33023530
Business address
POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
Open-market buys, last 90 days
$619,999
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$619,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-06 Knotnerus Tim Jasper Chief Executive Officer Purchase +5,000 $8.70 $44K 21,823
2026-10-05 Knotnerus Tim Jasper Chief Executive Officer Purchase +6,000 $8.48 $51K 16,823

Page 1 of 1 · 2 trades